Company Oncoprax Srl with Fiscal Code 34241534
recorded a turnover of 2024 of
71.601,
with a net profit of
24.816
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Oncoprax Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
6.662
34.464
34.731
38.847
46.410
40.863
46.885
47.975
54.855
71.601
Total Income - EUR
6.662
35.354
34.731
38.847
46.410
40.863
46.885
47.975
55.246
71.773
Total Expenses - EUR
11.843
27.624
24.702
30.557
36.531
35.415
38.326
40.026
41.923
44.851
Gross Profit/Loss - EUR
-5.181
7.730
10.029
8.290
9.879
5.448
8.558
7.949
13.323
26.921
Net Profit/Loss - EUR
-5.381
7.041
9.681
7.904
9.415
5.056
8.305
7.346
12.786
24.816
Employees
3
0
0
0
0
2
2
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 31.3%, from 54.855 euro in the year 2023, to 71.601 euro in 2024.
The Net Profit increased by 12.102 euro, from 12.786 euro in 2023, to 24.816 in the last year.
Check the financial reports for the company - Oncoprax Srl
Financial Rating - ONCOPRAX SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Oncoprax Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Oncoprax Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Oncoprax Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
34.332 euro in 2024 which includes Inventories of
72 euro, Receivables of
17.140 euro and cash availability of
17.119 euro.
The company's Equity was valued at
24.864 euro, while total Liabilities amounted to
13.095 euro.
Equity increased by 12.102 euro, from 12.834 euro in 2023, to 24.864 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Oncoprax Srl